Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Instil Bio

Clinical trials sponsored by Instil Bio, explained in plain language.

Instil Bio TIL NASDAQ

Clinical-stage biopharmaceutical company developing cell therapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Experimental immune cell therapy targets Hard-to-Treat cancers

Disease control Terminated

This early-phase trial tested a personalized cell therapy called ITIL-306 in people with advanced ovarian, lung, or kidney cancers that had not responded to standard treatments. The therapy uses a patient's own immune cells (TILs) taken from their tumor, modified to better attack…

Phase: PHASE1 • Sponsor: Instil Bio • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC